MX370302B - Composición de ropinirol para usarse en la inducción de emesis en los animales. - Google Patents

Composición de ropinirol para usarse en la inducción de emesis en los animales.

Info

Publication number
MX370302B
MX370302B MX2016003904A MX2016003904A MX370302B MX 370302 B MX370302 B MX 370302B MX 2016003904 A MX2016003904 A MX 2016003904A MX 2016003904 A MX2016003904 A MX 2016003904A MX 370302 B MX370302 B MX 370302B
Authority
MX
Mexico
Prior art keywords
emesis
animal
inducing emesis
inducing
composition
Prior art date
Application number
MX2016003904A
Other languages
English (en)
Other versions
MX2016003904A (es
Inventor
Kokkonen Johanna
Levijoki Jouko
Saloranta Lasse
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of MX2016003904A publication Critical patent/MX2016003904A/es
Publication of MX370302B publication Critical patent/MX370302B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un método para inducir emesis en animales, particularmente animales de compañía tales como perros y gatos, en situaciones donde se desea el vómito. El método comprende administrar una composición de gotas para los ojos que comprende un agonista selectivo de dopamina de la familia D2 como ingrediente activo, en el ojo del animal para inducir la emesis. El método y la composición son útiles en situaciones que involucran la ingestión de una sustancia potencialmente tóxica o un cuerpo extraño por el animal.
MX2016003904A 2013-09-30 2014-09-29 Composición de ropinirol para usarse en la inducción de emesis en los animales. MX370302B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361884924P 2013-09-30 2013-09-30
PCT/FI2014/000022 WO2015044504A1 (en) 2013-09-30 2014-09-29 A veterinary method for inducing emesis

Publications (2)

Publication Number Publication Date
MX2016003904A MX2016003904A (es) 2016-06-17
MX370302B true MX370302B (es) 2019-12-09

Family

ID=51845431

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003904A MX370302B (es) 2013-09-30 2014-09-29 Composición de ropinirol para usarse en la inducción de emesis en los animales.

Country Status (21)

Country Link
US (1) US10092510B2 (es)
EP (1) EP3052194B1 (es)
JP (1) JP6382993B2 (es)
KR (1) KR102277168B1 (es)
CN (1) CN105592889B (es)
AU (1) AU2014326576B2 (es)
BR (1) BR112016007057B1 (es)
CA (1) CA2922913C (es)
DK (1) DK3052194T3 (es)
ES (1) ES2878146T3 (es)
HR (1) HRP20211308T1 (es)
HU (1) HUE056109T2 (es)
LT (1) LT3052194T (es)
MX (1) MX370302B (es)
NZ (1) NZ717434A (es)
PL (1) PL3052194T3 (es)
PT (1) PT3052194T (es)
RU (1) RU2693492C2 (es)
SI (1) SI3052194T1 (es)
WO (1) WO2015044504A1 (es)
ZA (1) ZA201601468B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2943933T3 (es) * 2018-01-12 2023-06-16 Orion Corp Colirios de palonosetrón para el tratamiento o la prevención de náuseas y vómitos
AU2021216691A1 (en) 2020-02-03 2022-07-28 Orion Corporation Stable pharmaceutical compositions of ropinirole

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336490C (en) * 1988-06-03 1995-08-01 Paul Michael Iuvone Pharmacological treatment of ocular development
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
JP2008308488A (ja) * 2007-05-11 2008-12-25 Santen Pharmaceut Co Ltd 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤

Also Published As

Publication number Publication date
US10092510B2 (en) 2018-10-09
CN105592889B (zh) 2019-06-21
AU2014326576B2 (en) 2019-03-14
CA2922913A1 (en) 2015-04-02
JP2016531940A (ja) 2016-10-13
RU2693492C2 (ru) 2019-07-03
KR20160062130A (ko) 2016-06-01
US20160206555A1 (en) 2016-07-21
EP3052194B1 (en) 2021-06-16
MX2016003904A (es) 2016-06-17
ES2878146T3 (es) 2021-11-18
BR112016007057B1 (pt) 2023-04-11
JP6382993B2 (ja) 2018-08-29
KR102277168B1 (ko) 2021-07-15
CA2922913C (en) 2021-09-07
BR112016007057A2 (pt) 2017-08-01
SI3052194T1 (sl) 2021-09-30
LT3052194T (lt) 2021-07-12
CN105592889A (zh) 2016-05-18
RU2016116810A3 (es) 2018-07-02
HUE056109T2 (hu) 2022-01-28
RU2016116810A (ru) 2017-11-10
ZA201601468B (en) 2017-06-28
EP3052194A1 (en) 2016-08-10
PT3052194T (pt) 2021-07-06
HRP20211308T1 (hr) 2021-11-26
PL3052194T3 (pl) 2021-12-13
AU2014326576A1 (en) 2016-03-17
DK3052194T3 (da) 2021-07-26
WO2015044504A1 (en) 2015-04-02
NZ717434A (en) 2019-03-29

Similar Documents

Publication Publication Date Title
CL2014002087A1 (es) Composición veterinaria masticable que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal.
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
CL2017002936A1 (es) Compuestos ciclooctadepsipéptidos, composición veterinaria antihelmíntica, y uso para preparar un medicamento útil contra infección por parásitos o una infestación por parásitos internos o externos en un animal.
PH12015501891A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12016502003A1 (en) Novel bacteriophage and composition containing same
MX2015015941A (es) Composiciones ingeribles que contienen componente de aguacate criollo.
PH12017500708A1 (en) Probiotic and prebiotic compositions
PH12015501890A1 (en) Novel bacteriophage and antibacterial composition comprising the same
MX2016008128A (es) Intensificadores de aceptabilidad para alimento para mascotas, método de preparación y usos de los mismos.
TN2015000406A1 (en) Antimicrobial compositions and related methods of use
MX2022015141A (es) Composiciones y metodos de uso de un compuesto de control de inapetencia.
NZ706990A (en) A veterinary method of alleviating noise aversion
MX2019006773A (es) Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros.
IN2014DN08499A (es)
EA201500913A1 (ru) Противомикробные соединения и способы их получения и применения
MX370585B (es) Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico.
NZ717434A (en) A veterinary method for inducing emesis
AR097143A1 (es) Composición alimenticia mineral para lamer para rumiantes y método para prepararla
AU2013343676A8 (en) Powder composition for disinfection of the teats of dairy animals
CL2018001017A1 (es) Conservación de vitaminas hidrosolubles.
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
IN2014DN05976A (es)
CL2011002901A1 (es) Composicion veterinaria inyectable de liberacion prolongada y dosis unica que comprende microparticulas de polihidroxibutirato co-3-hidroxivalerato (phbv), un agente antimicrobiano seleccionado de ceftiofur o florfenicol y agua para inyeccion; procedimiento de preparacion; util para tratar infecciones en animales.
NZ701190A (en) Combination meloxicam and xylazine therapy in animals
UA86392U (ru) Способ повышения продуктивности и стрессоустойчивости свиней

Legal Events

Date Code Title Description
FG Grant or registration